Development of Solid Lipid Nanoparticles with Letrozole for Breast Cancer Treatment: in-vitro and in-vivo evaluation. (2022). Journal of Pharmaceutical Negative Results, 1159-1166. https://doi.org/10.47750/pnr.2022.13.S01.142